BearingPoint posts strong 2019 as it starts executing its Strategy 2025

 

Triton Digital Integrates DBSgroep’s RTVPLAN Media Sales Solution With Its Renowned Advertising Server

 

Shionogi Receives Positive CHMP Opinion for FETCROJA® (cefiderocol) for the Treatment of Infections Due to Aerobic Gram-Negative Bacteria in Adult Patients With Limited Treatment Options

 

Shionogi Receives Positive CHMP Opinion for FETCROJA® (cefiderocol) for the Treatment of Infections Due to Aerobic Gram-Negative Bacteria in Adult Patients With Limited Treatment Options

 

Harbour BioMed Announces U.S. FDA Approval of IND for Its Next Generation anti-CTLA-4 Antibody, HBM4003, to Treat Cancer

 

Pershing Square Holdings, Ltd. Announces Transactions in Own Shares

 

Topcon Technology Improving Paving of Roads, Runways, and Racetracks

 

InterXion Shareholders Approve All Proposals Related to Proposed Strategic Stock-for-Stock Combination with Digital Realty

 

Harbour BioMed Receives U.S. FDA IND Approval for Phase 2 Clinical Trial and Orphan Drug Designation for Anti-PD-L1 Monoclonal Antibody, HBM9167

 

NXP Semiconductors Expands Global Use of the Workiva Platform to Gain Efficiencies and Reduce Risk